Secure Access Manager (SAM)

Single Sign-On Solutions for the Life Sciences Industry

A customer logo grid of SAM SSO customers, including AstraZeneca, Merck, Pfizer, and Roche.

Exostar’s Secure Access Manager provides trusted SSO solutions for life sciences organizations. SAM is a single point of identity authentication for all of your services and applications, streamlining authentication and credential management for researchers, sponsors, contract research organizations, and other partners.

SAM combines subject matter expertise, vertical market experience, and broad industry acceptance. It is the SSO authentication platform of choice for:

  • 25+ of the largest global pharmaceutical companies
  • Over 30,000 life science organizations worldwide
  • 750,000+ Users
  • Access to the industry’s Shared Investigator Platform

Come join Exostar’s rapidly-growing life science community today – your partners likely already belong!

Drug R&D Challenges

The research and development (R&D) process for new drugs and therapies takes as long as a decade, costs upwards of $2 billion, and involves a wide variety of constituents.  Sponsors, Contract Research Organizations (CROs) and other third-party researchers, clinical trials sites, and other partners must securely access internal and external systems and applications and exchange sensitive and proprietary information throughout the process.  Clinical trials alone typically require each individual participant to receive a unique account and associated access information for each relevant system and application – introducing significant efficiency and security risks for all involved.

Secure Access Manager: SSO Solutions to Accelerate the R&D Process while Protecting Intellectual Property

Sponsors must engage CROs, sites, and other partners quickly, minimize administrative overhead, and ensure secure collaboration throughout the R&D process. Exostar’s Secure Access Manager SSO solutions help sponsors meet these objectives by supporting:

  • An architecture that only requires system and application owners to connect assets once, regardless of the number of partners that need access
  • Faster partner engagement via outsourced, optimized onboarding techniques
  • Delegated administration, where asset owners assign access privileges and the solution enforces them
  • Stronger information security against bots, phishing, or targeted system attacks with SSO multi-factor authentication via hardware tokens, software certificates, phone apps, and other multi-factor authentication options for asset access

SSO Solution: Solving the #1 Clinical Trials Technology Challenge

In a recent Society for Clinical Research Sites study, 40 percent of the over 500 life science industry sites surveyed cited too many systems requiring different processes and login credentials as their number one clinical trial technology challenge, and 90 percent ranked it in their top four. Exostar’s Secure Access Manager solves this credential management problem with a trusted single sign-on (SSO) solution that:

  • Gives authorized users a single login/account for SSO authentication on all internal and external systems and applications
  • Works across all connected sponsors and industry platforms, including the Shared Investigator Platform
  • Enhances productivity by reducing login times and the need to manage and maintain dozens of usernames and passwords